Article

Schizophrenia Q&A: Depot Medications in Schizophrenia Therapy

Author(s):

Peter F. Buckley, MD

In this video segment, Dr. Peter Buckley addresses 2 questions: • What factors do you consider when you offer depot medications to a patient with schizophrenia? • What can be done to encourage the use of depot medications?

In this video clip, Dr Peter Buckley addresses 2 questions:

• What factors do you consider when you offer depot medications to a patient with schizophrenia?
• What can be done to encourage the use of depot medications?

 

This video was originally posted on June 19, 2012 and has since been updated with permission from Dr Buckley. -Ed

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Related Videos
New Africa /Adobestock
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
A new treatment in development is poised to be a game-changer for patients with postpartum depression.
An expert discusses the latest on EndeavorRx and more digital therapeutics for this patient population.
Related Content
How effective are these agents for AUD treatment? An expert shares highlights from his 2024 ASCP Annual Meeting Pharmaceutical Pipeline Update presentation.
June 5th 2024

An Update on GLP-1 Receptor Agonists as Pharmacotherapies for AUD

Mehdi Farokhnia, MD, MPH
Comorbid Schizophrenia and Substance Use-Moving Toward Improved Functional Outcomes
November 8th 2012

Comorbid Schizophrenia and Substance Use-Moving Toward Improved Functional Outcomes

Douglas L. Noordsy, MD
Anita H. Clayton, MD, gives a preview of her upcoming poster presentation at the 2024 ASCP Annual Meeting.
May 30th 2024

Early Improvement of Symptoms in Bipolar 1 Depression

Anita H. Clayton, MD
Practical Approaches to Treating Early Stages of Schizophrenia
November 8th 2012

Practical Approaches to Treating Early Stages of Schizophrenia

S. Charles Schulz, MD
Anita H. Clayton, MD, welcomes us all to the 2024 ASCP Annual Meeting!
May 29th 2024

Exciting Possibilities at ASCP 2024

Anita H. Clayton, MD
An expert shares highlights from her panel presentation at the 2024 ASCP Annual Meeting.
May 28th 2024

Navigating New Treatments for PTSD

Lori Davis, MD
© 2025 MJH Life Sciences

All rights reserved.